Cure My Disease

Don't miss your cure!

 Log in / Sign up

New eczema ointment shows promise in early trial

NCT ID NCT07071610

Completed Symptom relief Sponsor: Lynk Pharmaceuticals Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested an experimental ointment called LNK01004 in 75 adults with moderate-to-severe atopic dermatitis (eczema). Participants applied the ointment twice daily for 8 weeks. The goal was to see if it reduces skin redness, swelling, and itching better than a placebo ointment. The trial is now complete, and results will help decide if larger studies are needed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
LNK01004 ointment
What this could lead to
If successful, this could lead to a new topical treatment option for people with moderate-to-severe atopic dermatitis, potentially easing itching and skin inflammation.
What could go wrong
This is an early Phase 2 trial with only 75 participants, so results may not apply to everyone. The ointment may not work better than a placebo, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Locations

  • Peking University People's Hospital

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.